Mythic Therapeutics Launches With New Approach To Improving Antibody Drug Conjugate Performance, Backed By $103 Million In Series B Financing
Round Type
Series B
WalthamBiotechnologyHealth CareScience And EngineeringDescription
Mythic Therapeutics today announced its launch to develop smarter and safer antibody-drug conjugates (ADCs) with an oversubscribed Series B financing round of $103 million. Viking Global Investors led the round, along with new investors including Venrock Healthcare Capital Partners, Foresite Capital, Perceptive Advisors, and Highside Capital. Existing Mythic investors participating in the round include Venrock, First Round Capital, OMX Ventures, Lifeforce Capital, and Refactor Capital. The proceeds from Mythic’s Series B will finance the lead program through first-in-human clinical studies in lung cancer and fund pipeline development.
Quick answer
Mythic Therapeutics raised an undisclosed amount in a Series B round, dated December 15, 2021. Mythic Therapeutics is based in Waltham, Massachusetts, United States.
- How much did Mythic Therapeutics raise?
- Mythic Therapeutics raised an undisclosed amount in a Series B round on December 15, 2021.
- What does Mythic Therapeutics do?
- Mythic Therapeutics is a product-platform company developing a pipeline of antibody-drug conjugates (ADCs) designed to exhibit unparalleled therapeutic index and efficacy.
- Where is Mythic Therapeutics based and how big is it?
- Mythic Therapeutics is based in Waltham, Massachusetts, United States. Fundz records about 48 employees.
- Who are the decision-makers at Mythic Therapeutics?
- Fundz holds 1 contact at Mythic Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Mythic Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Septerna raised $100M (Series A) on January 27, 2022.
- Advanced NanoTherapies raised $9.2M on January 26, 2022.
- Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
- Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
- Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.
- PostEra Inc. raised $26M on January 14, 2022.
Who to call at Mythic Therapeutics, and when
A new round usually means Mythic Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Mythic Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Mythic Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Mythic Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Mythic Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMythic Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.